Insider Transactions in Q3 2020 at Bristol Myers Squibb CO (BMY)
Insider Transaction List (Q3 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2020
|
Karen Murphy Santiago SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
220
-2.62%
|
$13,200
$60.97 P/Share
|
|
Sep 01
2020
|
Karen Murphy Santiago SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
642
+7.11%
|
-
|
|
Aug 31
2020
|
Giovanni Caforio Executive Chair of the Board |
SELL
Open market or private sale
|
Direct |
39,840
-8.21%
|
$2,470,080
$62.7 P/Share
|
|
Aug 17
2020
|
Joseph Eid SVP,Head Glob. Medical Affairs |
SELL
Open market or private sale
|
Direct |
5,327
-67.76%
|
$340,928
$64.0 P/Share
|
|
Aug 13
2020
|
Sandra Leung EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
141,420
-24.63%
|
$8,909,460
$63.24 P/Share
|
|
Aug 01
2020
|
David V Elkins EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,916
-32.11%
|
$1,503,128
$58.66 P/Share
|
|
Aug 01
2020
|
David V Elkins EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
46,402
+36.51%
|
-
|
|
Jul 01
2020
|
Karen Murphy Santiago SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
367
-4.52%
|
$21,653
$59.43 P/Share
|
|
Jul 01
2020
|
Karen Murphy Santiago SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,069
+11.64%
|
-
|
|
Jul 01
2020
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,463
-47.7%
|
$263,317
$59.43 P/Share
|
|
Jul 01
2020
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
BUY
Exercise of conversion of derivative security
|
Direct |
9,356
+50.0%
|
-
|